<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="126027">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01860274</url>
  </required_header>
  <id_info>
    <org_study_id>00-06</org_study_id>
    <nct_id>NCT01860274</nct_id>
  </id_info>
  <brief_title>Meshed Safen Graft Patency Trial</brief_title>
  <official_title>Randomized Prospective Comparison of Patency in Safen Vein Graft to the Diagonal Branch Under 1.5 mm</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cardiochirurgia E.H.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cardiochirurgia E.H.</source>
  <oversight_info>
    <authority>Italy: Ministry of Health</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study hypothesis is that a meshed conduit made of safen vein allows a better patency at
      mid-long term than a safen vein alone.

      To test this hypothesis the investigators plan a prospective, randomized study, comparing
      grafts to the diagonal, in cases of vessel diameter under 1.5mm. A control angiography will
      be performed one year after the operation.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Patency</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Patency of graft at coronary angiography, 12 month after operation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major Adverse Cardiac Events (MACE)</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Mesh</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bypass to the diagonal is performed with a composite conduit made including the patient safen vein into a mesh</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bypass to the diagonal branch is performed with a traditional safen vein.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Mesh</intervention_name>
    <arm_group_label>Mesh</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Control</intervention_name>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Indication to Coronary Artery Bypass Graft

          -  Diagonal branch with critical stenosis (over 70%)

          -  Diagonal branch diameter under 1.5 mm

        Exclusion Criteria:

        -
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luca Weltert, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>European Hospital - Rome</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ruggero De Paulis, MD</last_name>
    <role>Study Chair</role>
    <affiliation>European Hospital - Rome</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Luca Weltert, MD</last_name>
    <phone>3478880617</phone>
    <email>lweltert@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>European Hospital</name>
      <address>
        <city>Rome</city>
        <zip>00149</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Luca Weltert, MD</last_name>
      <phone>+39-3478880617</phone>
      <email>lweltert@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Luca Weltert, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>May 21, 2013</lastchanged_date>
  <firstreceived_date>May 20, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Mesh</keyword>
  <keyword>Graft</keyword>
  <keyword>Patency</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
